Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over
62 000 new cases occurred in men and women in 2015. The incidence continues to rise …

Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …

The growing detection of papillary thyroid microcarcinomas (PTMCs) is paralleled by an
increase in surgical procedures. Due to the frequent indolent nature, cost, and risk of …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Background Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Methods Six scientific Italian societies entitled to …

Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising
incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with …

Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …

Purpose To develop a deep learning–based computer-aided diagnosis (CAD) system for
use in the CT diagnosis of cervical lymph node metastasis (LNM) in patients with thyroid …

Background Two large randomised trials of patients with well-differentiated thyroid cancer
reported in 2012 (HiLo and ESTIMABL1) found similar post-ablation success rates at 6–9 …